Literature DB >> 19215677

How to increase the diagnostic value of malignancy-related ascites: discriminative ability of the ascitic tumour markers.

Y Tuzun1, S Yilmaz, M Dursun, F Canoruc, Y Celik, T Cil, T Boyraz.   

Abstract

Making a differential diagnosis between malignant and non-malignant ascites is an important clinical issue, but cytological examination has a relatively low diagnostic sensitivity. This study aimed to find a discriminative model that distinguished between malignancy-related and non-malignant ascites. The study included 107 patients: 50 with non-malignant and 57 with malignant ascites. Ascites was analysed using a range of tumour markers and standard cytology. Standardized canonical discriminant function coefficients were used to distinguish between ascites types. The combination of carbohydrate antigen (CA) 15-3, carcinoembryonic antigen (CEA) and cytokeratin 19 fragments (CYFRA-21.1) discriminated between malignancy-related ascites and non-malignant ascites with an accuracy of 98.8% compared with an accuracy of 77.8% for cytological examination. In conclusion, the use of a discriminant function constructed from a combination of CA15-3, CEA and CYFRA-21.1 could distinguish malignant from non-malignant ascites with greater accuracy than cytological examination. Further studies in larger population groups are warranted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19215677     DOI: 10.1177/147323000903700110

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  2 in total

1.  Atypical presentation of colon adenocarcinoma: a case report.

Authors:  Lynnette K Tumwine; Magid Kagimu; Ponsiano Ocama; Innocent Segamwenge; Noah Masiira-Mukasa; Dan Wamala; Otto Dworak; Christopher K Opio
Journal:  J Med Case Rep       Date:  2012-02-13

2.  Targeted Sequencing of Ascites and Peritoneal Washing Fluid of Patients With Gastrointestinal Cancers and Their Clinical Applications and Limitations.

Authors:  Go Eun Bae; Seok-Hwan Kim; Min Kyung Choi; Jin-Man Kim; Min-Kyung Yeo
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.